Biostage (BSTG) – FDA
-
Biostage (BSTG) Reports Publication Showing Rapid Esophageal Regeneration using the Biostage Esophageal Implant
-
Biostage (BSTG) Secures $1.1M Phase Phase II NIH SBIR Fast-Track Grant to Develop Cellspan Esophageal Implant
-
-
-
-
Back to BSTG Stock Lookup